Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder.

Wurcel, Alysse G; DeSimone, Daniel C; Marks, Laura; Baddour, Larry M; Sendi, Parham (2023). Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical microbiology and infection, 29(8), pp. 952-954. Elsevier 10.1016/j.cmi.2023.04.005

[img]
Preview
Text
1-s2.0-S1198743X2300160X-main.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (387kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research

UniBE Contributor:

Sendi, Parham

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1469-0691

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

13 Apr 2023 12:51

Last Modified:

08 May 2024 11:01

Publisher DOI:

10.1016/j.cmi.2023.04.005

PubMed ID:

37044275

BORIS DOI:

10.48350/181694

URI:

https://boris.unibe.ch/id/eprint/181694

Actions (login required)

Edit item Edit item
Provide Feedback